MetaCap

Artivion Inc. Company Profile

NYSE: AORTHealth CareMedical/Dental InstrumentsUSD

18.16-0.37 (-2.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Artivion at a glance

Artivion Inc. (NYSE: AORT) is a Medical/Dental Instruments company in the Health Care sector headquartered in Kennesaw, GA. Artivion is led by Mr. James Patrick Mackin and employs about 1,800 people. At a market capitalization of $886.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0000784199, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Artivion do?

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Business description based on the company's public filings.

Company information

Legal name
Artivion Inc.
Ticker
NYSE: AORT
Industry
Medical/Dental Instruments
CEO
Mr. James Patrick Mackin
Employees
1,800
Headquarters
1655 Roberts Boulevard NW, Kennesaw, GA, United States
Phone
770 419 3355
Market cap
$886.02M
SEC CIK
0000784199
Latest annual report
10-K · Feb 18, 2026

Companies similar to Artivion

AORT peer companies
CompanyPrice% ChgMarket capCompare
KIDSOrthoPediatrics Corp.31.74-2.37%$828.75Mvs AORT
VVVVvVARDIS Holding AG Class A14.55-3.00%$770.91Mvs AORT
SGPSpyGlass Pharma Inc.30.43-1.14%$1.02Bvs AORT
ATECAlphatec Holdings Inc.6.68-3.19%$1.02Bvs AORT
IARTIntegra LifeSciences Holdings Corporation13.25-2.21%$1.03Bvs AORT
IRMDiRadimed Corporation81.02-0.30%$1.04Bvs AORT
BBNXBeta Bionics Inc.13.36+0.30%$726.34Mvs AORT
SIBNSI-BONE Inc.23.73-0.08%$1.07Bvs AORT

Related